We were so proud to be highlighted at the NIH Innovation Forum at #BIO2024 - CEO Faraz A. Choudhury, Ph.D. sat down to chat about our exciting work in target discovery and oncology therapeutic development. Read more here - and reach out for more info! https://lnkd.in/eCy5v9fQ #PrecisionMedicine #Biotherapeutics #CancerResearch #antibodies #biotechnology
Immuto Scientific
Biotechnology Research
Madison, Wisconsin 720 followers
Breakthrough Technologies. Enabling Better Therapeutics.
About us
Immuto is a biotechnology company that is transforming the way biotherapeutics are discovered. Protein structural analysis is an essential step in the drug discovery process, and compared to all other methods used today, our suite of proprietary technologies enables assessment of drug binding, target conformation, and interactions with an unprecedented degree of accuracy and speed. With our industry leading structure-based platform, we enable the discovery of next generation therapeutics against the most challenging targets. Using our patented approach, we are on a mission to demystify and democratize protein structure, function, and dynamics - driving rationally designed drug development at unprecedented speed. Unlock rational design for biologics and reimagine drug discovery with us.
- Website
-
immutoscientific.com
External link for Immuto Scientific
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Madison, Wisconsin
- Type
- Privately Held
- Founded
- 2018
- Specialties
- biologics, structural biology, rational design, drug design, antibody engineering, antibody discovery, antibody drug conjugates, Structural proteomics, proteomics, affinity maturation, lead optimization, hematology, solid tumors, oncology, and mAbs
Locations
-
Primary
Get directions
2401 American Ln
Madison, Wisconsin 53704, US
Employees at Immuto Scientific
Updates
-
Immuto Scientific's CEO Faraz A. Choudhury, Ph.D. will be speaking at BIO tomorrow, June 4th, at 11:30 AM in the Company Presentation room - don't miss this chance to hear about our target discovery platform and collaboration opportunities! #BIO2024 https://lnkd.in/dKrXuHVa
-
-
Have you registered for BIO 2024? Immuto Scientific will be at this year's BIO International Convention in San Diego, CA. Faraz A. Choudhury, Ph.D., Hetal Marble, Ph.D. and Alexander Farahani are looking forward to connecting and collaborating June 3-6, 2024. #BIO2024 https://lnkd.in/dKrXuHVa
-
-
Immuto is proud to be a part of Wisconsin's burgeoning biotech economy - thank you Forward BIOLABS and Wisconsin Economic Development Corporation for your support of us and other entrepreneur-led companies in this great state!
We were ✨ THRILLED ✨ to host Wisconsin Economic Development Corporation's $100M investment into #Wisconsin's entrepreneurial ecosystem today, along with Governor Tony Evers and Missy Hughes. 🎤 Jessica Martin Eckerly welcomed the packed house of attendees and media for this historic announcement. Speakers included Vivek Swaminathan of Cardamom Health, Tom Still of Wisconsin Technology Council along with fund managers Carrie Thome, CFA of NVNG Investment Advisors, LLC, Elaine Coughlin of Idea Fund of La Crosse, David Arnstein of Venture Investors Health Fund, Mark Bakken of HealthX Ventures and Tim Hoerr of Serra Ventures, LLC. Watch the 📽 news tonight, we think every station was there to cover, including WMTV 15 News, WisconsinEye Public Affairs Network (livestream), Channel3 NOW, WisBusiness.com, WKOW-ABC 27, Spectrum News 1 and a special thank you to Charles Benson of WTMJ for a more in-depth piece featuring our entrepreneurs Guelay Bilen-Rosas of AyrFlo Innovation Labs, Inc. and Faraz A. Choudhury, Ph.D. of Immuto Scientific. 🔎 Watch our LinkedIn for more news to follow on this fantastic news for #Wisconsin! #entrepreneurs #biohealth #techhub #innovation Michael Polewski, Bianca Fung and Laura Marie Kaiser News 🗞 articles linked in comments!
-
-
Stop by Booth 611 at PEGS and enter to win an iPad! Also, learn about the unprecedented ways that Immuto is applying structure to antibody discovery and development - Hetal Marble, Ph.D., Daniel Benjamin, and Xander Kessler are on deck to chat!
-
-
It's a big week next week at Cambridge Healthtech Institute's #PEGSBoston conference - don't miss Immuto CSO Neal Goodwin, PhD, MBA's talk on epitope-first antibody discovery, including brand new data demonstrating our empirically-constrained, in silico affinity maturation - May 15th, 4:15 PM! Plus, Head of Commercial Hetal Marble, Ph.D. and CTO Daniel Benjamin will be at Booth 611 to discuss structural biology and rational design - drop by to say hello and learn about what's new for rational design of biologics!
-
-
Attending Festival of Biologics? Visit Immuto at Booth 243, grab a cup of coffee, and discuss the most advanced platform for structure-based screening!
-
-
We're excited to see everyone in the biologics community next week at Festival of Biologics 2024! Drop us a like or a heart if you'll be there! Let's meet in sunny San Diego - Hetal Marble, Ph.D. and Alexander Farahani will be onsite at Booth 243 discussing Immuto's latest and greatest - including new capabilities. Book a meeting with us: [email protected].
-
-
We're proud to be participating in the InSingulo AB/AstraZeneca "Challenges in GPCR Drug Discovery" symposium in Gothenburg, Sweden on April 18th - join CTO Daniel Benjamin as he talks about Immuto's unique approach to GPCR drug discovery! Register here: https://lnkd.in/dPAKfzGR
-
-
Immuto is proud to be a speaker at the upcoming Structure-Based Drug Design Summit in June - join us in Boston and learn about our approach combining structural proteomics with high-throughput epitope mapping for rational biologics design and ultra-fast development.
Calling all structural biologists, drug design, drug discovery experts... is the Structure-Based Drug Design Summit on your calendar? See more information here: https://ter.li/revtn9 Your early bird registration offer for the Structure-Based Drug Design Summit expires this Friday, March 22nd at midnight. This forum provides unparalleled industry insights and premium networking opportunities to harness integrative structural biology techniques including NMR, X-Ray Crystallography, Cryo-EM, and Cryo-ET to determine 3D structures of pharmacologically relevant targets and propel drug design. Download the official event guide, here - https://ter.li/revtn9, to see the complete guide of 26+ speakers, 26 case-study presentations, 12+ hours of networking, and maximum discounts of up to $850. Further 20% discounts are available for team bookings. ⚡2024 Partners⚡ Thermo Fisher Scientific, PROTEROS biostructures GmbH, CryoCloud, Immuto Scientific, Helix Biostructures, NanoImaging Services, Biortus 💡 Session spotlight 💡 - Unleashing the Potential: Cryo-EM’s Impact to Effectively Supercharge Structural Determination with Maryam Khoshouei, Principal Scientist, Novartis - Harnessing Cryo-ET in Practice to Illuminate the Potential in Structural Design with Elizabeth Villa, Assistant Professor, UCSD As the brand-new, industry-led, third-party, gathering of structural biology professionals, this is a must-attend event for all SBDD enthusiasts. Any questions please drop myself or a member of the SBDD team a message if you have any questions on how you can get involved, the agenda, or registration queries - hope to see you in Boston this June! Mehmet Gul Trevor M. Garth Jones #structurebaseddrugdesign #SBDD #drugdesign #drugdiscovery #discovery #development #design #structuralbiology #structurebased #cryoem #cryoet #nmr #xraycrystallography #crystallography #smallmolecules #peptides #biologics
-